E
Sintx Technologies, Inc. SINT
$3.36 $0.092.88% NASDAQ
Recommendation
Prev Close
$3.27
Volume
16,951
Avg Vol (90D)
627,244
Market Cap
$12.60M
Dividend & Yield
--
52-Week Range
$1.71 - $7.36
P/E (TTM)
--
EPS (TTM)
-$6.93
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride--PEEK ...
12/1/2025 - GuruFocus
Sintx Technologies signs supply agreement with EVONIK
12/1/2025 - TipRanks Financial Blog
Sintx Technologies signs supply agreement with EVONIK
12/1/2025 - The Fly
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
12/1/2025 - Globe Newswire
Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year
11/13/2025 - The Fly
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
11/13/2025 - Globe Newswire
Insider Buying: Sintx Technologies (NASDAQ:SINT) CIO Acquires 10,000 Shares of Stock
11/11/2025 - MarketBeat
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
11/10/2025 - Zacks Investment Research
Insider Buying: Gregg Honigblum Acquires 10,000 Shares of SINTX Technologies Inc (SINT)
11/10/2025 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
11/6/2025 - Zacks Investment Research
Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates
11/4/2025 - Zacks Investment Research
SINTX Technologies (SINT) Introduces OsseoSculpt to Enhance Bone Healing
11/3/2025 - GuruFocus
Sintx Technologies announces launch of OsseoSculpt
11/3/2025 - TipRanks Financial Blog
Sintx Technologies announces launch of OsseoSculpt
11/3/2025 - The Fly
SINTX Technologies Announces Launch of OsseoSculpt an Advanced Biologic for Use with SINAPTIC Foot & Ankle Osteotomy Wedge System
11/3/2025 - Globe Newswire
Sintx Technologies files to sell 1.74M shares of common stock for holders
10/23/2025 - The Fly
Integer (ITGR) Beats Q3 Earnings and Revenue Estimates
10/23/2025 - Zacks Investment Research
Insider Buying: Eric Olson Acquires Additional Shares of SINTX Technologies Inc (SINT)
10/21/2025 - GuruFocus
SINTX Technologies (SINT) Gains FDA Clearance for New Surgical System
10/20/2025 - GuruFocus
Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system
10/20/2025 - TipRanks Financial Blog
SINTX Technologies Receives FDA Clearance for SINAPTIC Foot & Ankle Implant System
10/20/2025 - Globe Newswire
DCOR's Underlying Holdings Could Mean 13% Gain Potential
10/17/2025 - ETF Channel
What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?
10/16/2025 - Zacks Investment Research
UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
10/16/2025 - Globe Newswire
SINTX Technologies (SINT) Secures Patent for Antipathogenic Fabric Technology
10/14/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$1.27M
EBITDA (TTM)
-$9.26M
EBIT (TTM)
-$9.63M
Net Income (TTM)
-$9.84M
Balance Sheet
Total Assets (Q)
$11.36M
Total Debt (Q)
$3.39M
Total Liabilities (Q)
$7.30M
Book Value Per Share (Q)
$1.13
Cash Flow
Cash from Operations (TTM)
-$7.35M
Cash from Investing (TTM)
$965.00K
Cash from Financing (TTM)
$7.82M
Net Change in Cash (TTM)
$1.44M
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
1.19
7-Day Total Return
0.72%
30-Day Total Return
0.42%
60-Day Total Return
-26.71%
90-Day Total Return
20.15%
Year to Date Total Return
-7.83%
1-Year Total Return
-16.73%
2-Year Total Return
-95.63%
3-Year Total Return
-99.86%
5-Year Total Return
-99.99%
52-week Low
Apr 16, 2025 - $1.71
52-week High
Feb 21, 2025 - $7.36
Valuation
Market Cap
$12.60M - Nano Cap
Enterprise Value
$9.74M
Price/Sales (TTM)
7.63
Price/Book (Q)
2.91
Dividends and Shares
Shares Outstanding
2.96
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sintx.com
Phone Number
801 839 3500
Address
1885 West 2100 South
Salt Lake City, UT 84119
Country
United States
Year Founded
1996
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical... more
NASDAQ 12/02/2025 9:58AM Eastern Quotes delayed